1.Identifying purgative targets of sennoside A via in situ biotransformation of prodrug-based probes.
Zhen LIU ; Xinyue GENG ; Xinyue LIU ; Mengru LI ; Xiang LI ; Zhixin ZHANG ; Gan LUO ; Ying WANG ; Xiaoyan GAO
Journal of Pharmaceutical Analysis 2025;15(4):101078-101078
•A strategy for in situ metabolically synthesized active drug-based probes was proposed.•The potential purgative targets of SA were successfully hooked and identified.•The work provided a new insight for studying the direct targets of unstable active drugs.
2.Research progress in biomimetic nanosystems for biotoxin detoxification
Xinyue GAN ; Juxingsi SONG ; Shuaijun ZOU ; Qianqian WANG ; Liming ZHANG
Chinese Journal of Pharmacology and Toxicology 2025;39(4):310-320
Biotoxins are natural chemical substances produced by animals,plants or microorgan-isms that exhibit toxicity toward other species.These biotoxins exhibit a wide range of structural complexi-ties.Some of them are highly toxic,posing significant threats to human health and public safety.In recent years,researchers have employed the cell membranes of biotoxin target cells to coat nanomate-rials,thereby constructing biomimetic nanosystems with high biocompatibility,low immunogenicity,prolonged circulation time,and strong targeting capabilities.By leveraging the interactions between biotoxins and their target cell membranes,these systems effectively trap toxins,leading to notable advancements in this field.This article reviews the toxic mechanisms of biotoxins,the historical devel-opment of using biomimetic nanosystems for toxin detoxification,common preparation methods and characterization techniques,as well as the composition and detoxification efficacy of these nanosys-tems,thus providing references for their future design,development,and application.
3.Interpretation of the group standard of " Humanistic Caring Management Standards for Patients in the Operating Room"
Ruiying YU ; Xinyue MIAO ; Qingmin ZHANG ; Yilan LIU ; Shujie GUO ; Huiling LI ; Guo CHEN ; Chunlan ZHOU ; Ting LIU ; Shuhua DENG ; Hongzhen XIE ; Yu CHENG ; Yinglan LI ; Yanlan MA ; Xia XIN ; Yanjin LIU ; Yongyi CHEN ; Gendi LU ; Xiaoqin GAN ; Feng XU ; Zuwei XIA ; Li HE ; Qinqin CHEN ; Fukang ZHANG ; Songmei WU ; Yi LI ; Wenjuan ZHOU
Chinese Journal of Hospital Administration 2025;41(7):512-517
Humanistic caring for patients in the operating room refers to providing the whole process of caring medical services for patients in the operating room. In order to standardize humanistic caring services for patients in the operating room of medical institutions, improve the comprehensive service level of the operating room, and enhance the surgical experience of patients, the Chinese Association for Life Care released the group standard " Humanistic Caring Management Standards for Patients in the Operating Room" in December 2023. This article interpreted the basic requirements for humanistic caring of patients in the operating room, the environment and facilities for humanistic caring, the procedures and measures for humanistic caring, and the quality management framework, aiming to assist administrators and clinical practitioners across various levels of medical institutions in accurately understanding and effectively implementing the standard, and to provide essential textual reference and practical guidance for promoting the application of the standard.
4.Research progress in biomimetic nanosystems for biotoxin detoxification
Xinyue GAN ; Juxingsi SONG ; Shuaijun ZOU ; Qianqian WANG ; Liming ZHANG
Chinese Journal of Pharmacology and Toxicology 2025;39(4):310-320
Biotoxins are natural chemical substances produced by animals,plants or microorgan-isms that exhibit toxicity toward other species.These biotoxins exhibit a wide range of structural complexi-ties.Some of them are highly toxic,posing significant threats to human health and public safety.In recent years,researchers have employed the cell membranes of biotoxin target cells to coat nanomate-rials,thereby constructing biomimetic nanosystems with high biocompatibility,low immunogenicity,prolonged circulation time,and strong targeting capabilities.By leveraging the interactions between biotoxins and their target cell membranes,these systems effectively trap toxins,leading to notable advancements in this field.This article reviews the toxic mechanisms of biotoxins,the historical devel-opment of using biomimetic nanosystems for toxin detoxification,common preparation methods and characterization techniques,as well as the composition and detoxification efficacy of these nanosys-tems,thus providing references for their future design,development,and application.
5.Interpretation of the group standard of " Humanistic Caring Management Standards for Patients in the Operating Room"
Ruiying YU ; Xinyue MIAO ; Qingmin ZHANG ; Yilan LIU ; Shujie GUO ; Huiling LI ; Guo CHEN ; Chunlan ZHOU ; Ting LIU ; Shuhua DENG ; Hongzhen XIE ; Yu CHENG ; Yinglan LI ; Yanlan MA ; Xia XIN ; Yanjin LIU ; Yongyi CHEN ; Gendi LU ; Xiaoqin GAN ; Feng XU ; Zuwei XIA ; Li HE ; Qinqin CHEN ; Fukang ZHANG ; Songmei WU ; Yi LI ; Wenjuan ZHOU
Chinese Journal of Hospital Administration 2025;41(7):512-517
Humanistic caring for patients in the operating room refers to providing the whole process of caring medical services for patients in the operating room. In order to standardize humanistic caring services for patients in the operating room of medical institutions, improve the comprehensive service level of the operating room, and enhance the surgical experience of patients, the Chinese Association for Life Care released the group standard " Humanistic Caring Management Standards for Patients in the Operating Room" in December 2023. This article interpreted the basic requirements for humanistic caring of patients in the operating room, the environment and facilities for humanistic caring, the procedures and measures for humanistic caring, and the quality management framework, aiming to assist administrators and clinical practitioners across various levels of medical institutions in accurately understanding and effectively implementing the standard, and to provide essential textual reference and practical guidance for promoting the application of the standard.
6.Prognosis Analysis of Additional Surgical Treatment for High-Risk T1 Colorectal Cancer Patients After Endoscopic Resection
Xinyue LUO ; Yuxiang CHEN ; Jinlin YANG ; Kai DENG ; Junchao WU ; Tao GAN
Journal of Sichuan University (Medical Sciences) 2024;55(2):411-417
Objective To analyze the effect of additional surgery on the survival and prognosis of high-risk T1 colorectal cancer patients who have undergone endoscopic resection.Methods The clinical data of patients with high-risk T1 colorectal cancer were retrospectively collected.The patients were divided into the endoscopic resection(ER)plus additional surgical resection(SR)group,or the ER+SR group,and the ER group according to whether additional SR were performed after ER.Baseline data of the patients and information on the location,size,and postoperative pathology of the lesions were collected.Patient survival-related information was obtained through the medical record system and patient follow-up.The primary outcome indicators were the overall survival and the colorectal cancer-specific survival.Univariate Cox regression analysis was used to screen survival-related risk factors and hazard ratio(HR)was calculated.Multivariate Cox regression analysis was used to analyze the independent influencing factors.Results The data of 109 patients with T1 high-risk colorectal cancer were collected,with 52 patients in the ER group and 57 patients in the ER+SR group.The mean age of patients in the ER group was higher than that in the ER+SR group(65.21 years old vs.60.54 years old,P=0.035),and the median endoscopic measurement of the size of lesions in the ER group was slightly lower than that in the ER+SR group(2.00 cm vs.2.50 cm,P=0.026).The median follow-up time was 30.00 months,with the maximum follow-up time being 119 months,in the ER+SR group and there were 4 patients deaths,including one colorectal cancer-related death.Whereas the median follow-up time in the ER group was 28.50 months,with the maximum follow-up time being 78.00 months,and there were 4 patient deaths,including one caused by colorectal cancer.The overall 5-year cumulative survival rates in the ER+SR group and the ER group were 94.44%and 81.65%,respectively,and the cancer-specific 5-year cumulative survival rates in the ER+SR group and the ER group were 97.18%and 98.06%,respectively.The Kaplan-Meier analysis showed no significant difference in the overall cumulative survival or cancer-specific cumulative survival between the ER+SR and the ER groups.Univariate Cox regression analysis showed that age and the number of reviews were the risk factors of overall survival(HR=1.16 and HR=0.27,respectively),with age identified as an independent risk factor of overall survival in the multivariate Cox regression analysis(HR=1.10,P=0.045).Conclusion For T1 colorectal cancer patients with high risk factors after ER,factors such as patient age and their personal treatment decisions should not be overlooked.In clinical practice,additional caution should be exercised in decision-making concerning additional surgery.
7. Application of Baduanjin combined with health education in patients of heart failure with preserved ejection fraction
Xinyue LI ; Rihui ZHOU ; Haoyun GAN ; Xuan JIANG ; Hongyuan WEN
International Journal of Traditional Chinese Medicine 2018;40(8):698-701
Objective:
To explore the effect of

Result Analysis
Print
Save
E-mail